Antifungal Effects of rhGM-CSF in Patients After Allo-HSCT
This study is enrolling participants by invitation only.
Sponsor:
Xiamen Amoytop Biotech Co., Ltd.
Collaborator:
Shanghai First People's Hospital
Information provided by:
Xiamen Amoytop Biotech Co., Ltd.
ClinicalTrials.gov Identifier:
NCT01232504
First received: October 25, 2010
Last updated: July 10, 2011
Last verified: July 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is enrolling participants by invitation only. |
|---|---|
| Estimated Study Completion Date: | December 2011 |
| Estimated Primary Completion Date: | August 2011 (Final data collection date for primary outcome measure) |